Welcome to LookChem.com Sign In|Join Free

CAS

  • or

340312-91-6

Post Buying Request

340312-91-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

340312-91-6 Usage

Class

pyrrole derivatives

Derivative of

benzoic acid

Composition

benzene ring substituted with carboxylic acid group and pyrrole ring with two methyl groups at positions 2 and 5

Potential applications

medicinal chemistry and drug development

Specific uses and functions

dependent on further research and testing

Check Digit Verification of cas no

The CAS Registry Mumber 340312-91-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,0,3,1 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 340312-91:
(8*3)+(7*4)+(6*0)+(5*3)+(4*1)+(3*2)+(2*9)+(1*1)=96
96 % 10 = 6
So 340312-91-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H15NO2/c1-9-8-12(14(16)17)6-7-13(9)15-10(2)4-5-11(15)3/h4-8H,1-3H3,(H,16,17)

340312-91-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2,5-dimethylpyrrol-1-yl)-3-methylbenzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:340312-91-6 SDS

340312-91-6Upstream product

340312-91-6Downstream Products

340312-91-6Relevant articles and documents

Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same

-

, (2009/05/29)

The present disclosure relates to methods for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure further relates to compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure also relates to methods for identifying compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 340312-91-6